Systematic review: Coca-Cola can effectively dissolve gastric phytobezoars as a first-line treatment
Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis
Review article: liver transplantation for the pulmonary disorders of portal hypertension
NICE clinical guideline (CG152): the management of Crohn's disease in adults, children and young people
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease – a nationwide cohort study
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
Performance of Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study
Rumination variations: aetiology and classification of abnormal behavioural responses to digestive symptoms based on high-resolution manometry studies
Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers – authors' reply
Commentary: a gastrin antagonist against carcinoids – implications for PPI-induced hypergastrinaemia
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome – author's reply
Commentary: a comparison of glucagon-like peptides 1 and 2
Letter: detection of infliximab levels and anti-infliximab antibodies — comparison of three different assays
Letter: detection of infliximab levels and anti-infliximab antibodies – comparison of three different assays; authors' reply
Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis
Letter: diagnostic accuracy of M30 levels for identifying patients with non-alcoholic steatohepatitis – authors' reply
Letter: colorectal cancer screening
Letter: colorectal cancer screening – author's reply
Letter: Clostridium difficile colitis in patients with ulcerative colitis
Corrigendum